These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 9524294)

  • 21. Earlier diagnosis of HIV-1 infection by simultaneous detection of p24 antigen and antibody IgGs to p17 and reverse transcriptase in serum with enzyme immunoassay.
    Hashida S; Hashinaka K; Nishikata I; Saito A; Takamizawa A; Shinagawa H; Ishikawa E
    J Clin Lab Anal; 1996; 10(4):213-9. PubMed ID: 8811465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential maturation of avidity of IgG antibodies to gp41, p24 and p17 following infection with HIV-1.
    Thomas HI; Wilson S; O'Toole CM; Lister CM; Saeed AM; Watkins RP; Morgan-Capner P
    Clin Exp Immunol; 1996 Feb; 103(2):185-91. PubMed ID: 8565298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Shortening of the window period in diagnosis of HIV-1 infection by simultaneous detection of p24 antigen and antibody IgG to p17 and reverse transcriptase in serum with ultrasensitive enzyme immunoassay.
    Hashida S; Hashinaka K; Nishikata I; Oka S; Shimada K; Saito A; Takamizawa A; Shinagawa H; Ishikawa E
    J Virol Methods; 1996 Oct; 62(1):43-53. PubMed ID: 8910647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and persistence of antibody titers to recombinant HIV-1 core and matrix proteins in HIV-1 infection.
    Janvier B; Mallet F; Cheynet V; Dalbon P; Vernet G; Besnier JM; Choutet P; Goudeau A; Mandrand B; Barin F
    J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):898-903. PubMed ID: 8315575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The affinity of IgG antibodies to gag p24 and p17 in HIV-1-infected patients correlates with disease progression.
    Chargelegue D; Stanley CM; O'Toole CM; Colvin BT; Steward MW
    Clin Exp Immunol; 1995 Feb; 99(2):175-81. PubMed ID: 7851008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
    Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
    J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decline in CTL and antibody responses to HIV-1 p17 and p24 antigens in HIV-1-infected hemophiliacs irrespective of disease progression. A 5-year follow-up study.
    O'Toole CM; Lowdell MW; Chargelegue D; Colvin BT
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1361-8. PubMed ID: 1281655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunization of human HIV-seronegative volunteers with recombinant p17/p24:Ty virus-like particles elicits HIV-1 p24-specific cellular and humoral immune responses.
    Martin SJ; Vyakarnam A; Cheingsong-Popov R; Callow D; Jones KL; Senior JM; Adams SE; Kingsman AJ; Matear P; Gotch FM
    AIDS; 1993 Oct; 7(10):1315-23. PubMed ID: 8267904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conjugation of recombinant reverse transcriptase of HIV-1 to beta-D-galactosidase from Escherichia coli for ultrasensitive enzyme immunoassay (immune complex transfer enzyme immunoassay) of anti-HIV-1 IgG.
    Hashinaka K; Hashida S; Saitoh A; Nakata A; Shinagawa H; Oka S; Shimada K; Ishikawa E
    J Immunol Methods; 1994 Jun; 172(2):179-87. PubMed ID: 7518483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measurement of human immunodeficiency virus type 1 p24 in serum by an ultrasensitive enzyme immunoassay, the two-site immune complex transfer enzyme immunoassay.
    Hashida S; Hashinaka K; Nishikata I; Oka S; Shimada K; Saitoh A; Takamizawa A; Shinagawa H; Ishikawa E
    J Clin Microbiol; 1995 Feb; 33(2):298-303. PubMed ID: 7714182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultrasensitive and more specific enzyme immunoassay (immune complex transfer enzyme immunoassay) for p24 antigen of HIV-1 in serum using affinity-purified rabbit anti-p24 Fab' and monoclonal mouse anti-p24 Fab'.
    Hashida S; Hashinaka K; Nishikata I; Saito A; Takamizawa A; Shinagawa H; Ishikawa E
    J Clin Lab Anal; 1996; 10(5):302-7. PubMed ID: 8887010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
    Lottersberger J; Salvetti JL; Beltramini LM; Tonarelli G
    Rev Argent Microbiol; 2004; 36(4):151-7. PubMed ID: 15786866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of antibodies to the core protein P17, a serological marker during HIV-1 infection.
    Mehta SU; Rupprecht KR; Hunt JC; Kramer DE; McRae BJ; Allen RG; Dawson GJ; Devare SG
    AIDS Res Hum Retroviruses; 1990 Apr; 6(4):443-54. PubMed ID: 1692727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant p51 as antigen in an immune complex transfer enzyme immunoassay of immunoglobulin G antibody to human immunodeficiency virus type 1.
    Hashinaka K; Hashida S; Nishikata I; Adachi A; Oka S; Ishikawa E
    Clin Diagn Lab Immunol; 2000 Nov; 7(6):967-76. PubMed ID: 11063508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune complex transfer enzyme immunoassay for (anti-human T-cell leukemia virus type I) IgG in serum using a synthetic peptide, Cys-Gag p19(100-130), as antigen.
    Kohno T; Sakoda I; Suzuki M; Izumi A; Ishikawa E
    J Clin Lab Anal; 1991; 5(5):307-16. PubMed ID: 1682432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitive enzyme immunoassay (immune complex transfer enzyme immunoassay) for (anti-human T-cell leukemia virus type I) IgG in serum using recombinant gag p24(14-214) as antigen.
    Kohno T; Hirota K; Sakoda I; Yamasaki M; Yokoo Y; Ishikawa E
    J Clin Lab Anal; 1992; 6(5):302-10. PubMed ID: 1403350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fine specificity of IgG subclass response to group antigens in HIV-1-infected patients.
    Broliden PA; Morfeldt-Månsson L; Rosen J; Jondal M; Wahren B
    Clin Exp Immunol; 1989 May; 76(2):216-21. PubMed ID: 2503275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polyfunctional CD4(+) T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine.
    Van Braeckel E; Desombere I; Clement F; Vandekerckhove L; Verhofstede C; Vogelaers D; Leroux-Roels G
    Vaccine; 2013 Aug; 31(36):3739-46. PubMed ID: 23707169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reliable confirmation and quantitation of human immunodeficiency virus type 1 antibody using a recombinant-antigen immunoblot assay.
    Busch MP; el Amad Z; McHugh TM; Chien D; Polito AJ
    Transfusion; 1991 Feb; 31(2):129-37. PubMed ID: 1899951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression and characterization of HIV-1 Gag p17-p24 protein].
    Li TY; Jin NY; Wang HW; Guo ZR; Fang HH; An RG; Yin Z
    Sheng Wu Gong Cheng Xue Bao; 2000 Jan; 16(1):65-8. PubMed ID: 10883279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.